| 1 |
28940978 | Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. | 2017 Dec |
1 |
| 2 |
26884289 | Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels. | 2016 |
2 |
| 3 |
25931040 | Comparison of the effects of short-term hypolipidaemic treatment on plasma adipokine levels in men and women with isolated hypercholesterolaemia. | 2015 |
1 |
| 4 |
26320293 | [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus]. | 2015 |
1 |
| 5 |
28294846 | [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and With Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokynes Levels in Patients With Coronary Artery Disease and Diabetes Mellitus]. | 2015 Mar |
1 |
| 6 |
25185849 | The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia. | 2014 |
1 |
| 7 |
23033884 | Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study. | 2012 Dec |
1 |
| 8 |
20075600 | The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. | 2010 Feb |
1 |
| 9 |
16188393 | Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver. | 2006 |
1 |